keytruda Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Dana-Farber Cancer Institute (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadmeasurable disease

I am/have/hadhair thinning

I am/have/hadHER2

I am/have/hadneuropathy

I am/have/hadperiodic abstinence

I am/have/hadinvasive breast cancer

I am/have/hadcentral nervous system disorder

I am/have/hadbrain metastasis

I am/have/hadoophorectomy

I am/have/hadaptt

I am/have/hadcentral nervous system disease

I am/have/hadmetastasis

I am/have/hadbreast cancer

I am/have/hadanticoagulant therapy

I am/have/hadstage iv breast cancer

I am/have/hadliver metastasis

I am/have/hadalopecia

I am/have/hadtubal ligation

I am/have/hadestrogen

I am/have/hadprogrammed cell death 1 ligand 1

added new label for I am/have/had

more

I am looking for

I am looking foradjuvant

I am looking forsacituzumab govitecan

I am looking formk-3475

I am looking forpembrolizumab

I am looking forkeytruda

I am looking forimmunostimulant

I am looking foririnotecan

I am looking forestrogen

I am looking forcopper

I am looking forimmunomodulators

I am looking forprogesterone

I am looking foranticoagulants

I am looking forbisphosphonate

I am looking forcorticosteroids

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Cardiovascular Diseases
Recruiting

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

The names of the study interventions involved in this study are: Sacituzumab govitecan (IMMU-132) Pembrolizumab (Keytruda; MK-3475)

pembrolizumab

immunostimulant

neuropathy

invasive breast cancer

central nervous system disorder

8 views
05 Aug, 2020

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.